Gyre Therapeutics (GYRE) Profit After Tax (2010 - 2026)
Gyre Therapeutics (GYRE) reported Profit After Tax of -$9.9 million for Q1 2026, down 364.01% year-over-year from $3.7 million in Q1 2025, and down 621.67% on a QoQ basis from -$1.4 million in Q4 2025.
Gyre Therapeutics (GYRE) has 17 years of Profit After Tax data on file, last reported at -$9.9 million in Q1 2026.
- Quarterly Profit After Tax fell 364.01% year-over-year to -$9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 131.73% YoY) and the FY2025 annual result came in at $9.9 million, down 44.8% from the prior year.
- Profit After Tax retreated to -$9.9 million in Q1 2026 per GYRE's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at $51.6 million in Q2 2022 and bottomed at -$101.0 million in Q4 2023.
- The 5-year median for Profit After Tax is $2.9 million (2024), against an average of -$3.7 million.
- The widest annual swing landed in 2022, when Profit After Tax surged 359.09%; it then slumped 364.01% in 2026.
- Tracing GYRE's Profit After Tax over 5 years: stood at -$27.9 million in 2022, then plunged by 261.95% to -$101.0 million in 2023, then jumped by 100.56% to $569000.0 in 2024, then tumbled by 340.07% to -$1.4 million in 2025, then slumped by 621.67% to -$9.9 million in 2026.
- Per Business Quant, the three latest GYRE Profit After Tax figures stand at -$9.9 million (Q1 2026), -$1.4 million (Q4 2025), and $5.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -9.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.86 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | 5.94 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 569,000.00 |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 9.94 Mn |
| Dec 31, 2023 | -100.98 Mn |
| Sep 30, 2023 | 7.51 Mn |
| Jun 30, 2023 | 3.77 Mn |
| Mar 31, 2023 | 4.22 Mn |
| Dec 31, 2022 | -27.90 Mn |
| Sep 30, 2022 | -4.88 Mn |
| Jun 30, 2022 | 51.63 Mn |
| Mar 31, 2022 | -14.54 Mn |
| Dec 31, 2021 | -20.33 Mn |
| Sep 30, 2021 | -25.24 Mn |
| Jun 30, 2021 | -19.93 Mn |
| Mar 31, 2021 | -22.44 Mn |
| Dec 31, 2020 | -18.91 Mn |
| Sep 30, 2020 | -16.03 Mn |
| Jun 30, 2020 | -17.25 Mn |
| Mar 31, 2020 | -4.05 Mn |
| Dec 31, 2019 | -13.61 Mn |
| Sep 30, 2019 | -12.71 Mn |
| Jun 30, 2019 | -13.78 Mn |
| Mar 31, 2019 | -15.08 Mn |
| Dec 31, 2018 | -10.84 Mn |
| Sep 30, 2018 | -7.69 Mn |
| Jun 30, 2018 | -6.48 Mn |
| Mar 31, 2018 | -5.04 Mn |
| Dec 31, 2017 | -5.75 Mn |
| Sep 30, 2017 | -5.79 Mn |
| Jun 30, 2017 | -5.88 Mn |
| Mar 31, 2017 | -4.14 Mn |
| Dec 31, 2016 | -3.75 Mn |
| Sep 30, 2016 | -4.77 Mn |
| Jun 30, 2016 | -4.83 Mn |
| Mar 31, 2016 | -3.59 Mn |
| Dec 31, 2015 | -5.13 Mn |
| Sep 30, 2015 | -5.05 Mn |
| Jun 30, 2015 | -1.72 Mn |
| Mar 31, 2015 | -2.86 Mn |
| Dec 31, 2014 | -1.30 Mn |
| Sep 30, 2014 | -1.50 Mn |
| Jun 30, 2014 | -2.08 Mn |
| Mar 31, 2014 | -1.73 Mn |
| Dec 31, 2013 | -13.37 Mn |
| Sep 30, 2013 | -12.90 Mn |
| Jun 30, 2013 | -12.37 Mn |
| Mar 31, 2013 | -8.07 Mn |
| Dec 31, 2012 | -15.87 Mn |
| Sep 30, 2012 | -7.88 Mn |
| Jun 30, 2012 | 14.49 Mn |
| Mar 31, 2012 | 2.26 Mn |
| Dec 31, 2011 | -9.81 Mn |
| Sep 30, 2011 | -9.05 Mn |
| Jun 30, 2011 | -2.26 Mn |
| Mar 31, 2011 | 12.59 Mn |
| Dec 31, 2010 | -2.16 Mn |
| Sep 30, 2010 | 2.49 Mn |
| Jun 30, 2010 | 3.78 Mn |